A Phase 2 Study of SYM-1219 to Treat Bacterial Vaginosis
Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to test the safety and effectiveness of the oral
investigational new drug, SYM-1219, for the treatment of bacterial vaginosis.